Innate immunity to Toxoplasma gondii infection

Nature Reviews Immunology

Volumn 14, Issue 2, 2014, Pages 109-121

  Yarovinsky, Felix ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INFLAMMASOME; INTERLEUKIN 12; MYELOID DIFFERENTIATION FACTOR 88; NITROGEN OXIDE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 12; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

CELL SURFACE; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNODETECTION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; MYELOID DIFFERENTIATION FACTOR 88; NEUTROPHILS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTORS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84893115383     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3598     Document Type: Review

References (156)

1. Jordan, K. A. and Hunter, C. A. Regulation of CD8+ T cell responses to infection with parasitic protozoa. Exp. Parasitol. 126, 318-325 (2010).
2. Gaddi, P. J. and Yap, G. S. Cytokine regulation of immunopathology in toxoplasmosis. Immunol. Cell Biol. 85, 155-159 (2007).
3. Denkers, E. Y. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect. 1, 699-708 (1999).
4. Hunter, C. A. and Sibley, L. D. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nature Rev. Microbiol. 10, 766-778 (2012).
5. Takeuchi, O. and Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
6. Yarovinsky, F. et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308, 1626-1629 (2005).
7. Plattner, F. et al. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 3, 77-87 (2008).
8. Campos, M. A. et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167, 416-423 (2001).
9. Debierre-Grockiego, F. et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J. Immunol. 179, 1129-1137 (2007).
10. Benson, A., Pifer, R., Behrendt, C. L., Hooper, L. V. and Yarovinsky, F. Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe 6, 187-196 (2009).
11. Scanga, C. A. et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168, 5997-6001 (2002).
12. Jankovic, D. et al. In the absence of IL-12, CD4+ T cell responses to intracellular pathogens fail to default to a TH2 pattern and are host protective in an IL-10-/- setting. Immunity 16, 429-439 (2002).
13. Yarovinsky, F., Kanzler, H., Hieny, S., Coffman, R. L. and Sher, A. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response. Immunity 25, 655-664 (2006).
14. Hou, B., Benson, A., Kuzmich, L., DeFranco, A. L. and Yarovinsky, F. Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors. Proc. Natl Acad. Sci. USA 108, 278-283 (2011).
15. Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1, 1-13 (1989).
16. Pifer, R., Benson, A., Sturge, C. R. and Yarovinsky, F. UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii. J. Biol. Chem. 286, 3307-3314 (2011).
17. Pifer, R. and Yarovinsky, F. Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol. 27, 388-393 (2011).
18. Raetz, M. et al. Cooperation of TLR12 and TLR11 in the IRF8-dependent IL-12 response to Toxoplasma gondii profilin. J. Immunol. 191, 4818-4827 (2013).
19. Koblansky, A. A. et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38, 119-130 (2013).
20. Andrade, W. A. et al. Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice. Cell Host Microbe 13, 42-53 (2013).
21. Pepper, M. et al. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J. Immunol. 180, 6229-6236 (2008).
22. Melo, M. B. et al. UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog. 6, 1001071 (2010).
23. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. and Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
24. Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529 (2004).
25. Mancuso, G. et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nature Immunol. 10, 587-594 (2009).
26. Diebold, S. S. et al. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 36, 3256-3267 (2006).
27. Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669-1672 (2006).
28. Edwards, A. D. et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33, 827-833 (2003).
29. Reis e Sousa, C. et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186, 1819-1829 (1997).
30. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
31. Haas, T. et al. The DNA sugar backbone 2Ŷ deoxyribose determines toll-like receptor 9 activation. Immunity 28, 315-323 (2008).
32. Leadbetter, E. A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002).
33. Christensen, S. R. et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202, 321-331 (2005).
34. Gissot, M., Choi, S. W., Thompson, R. F., Greally, J. M. and Kim, K. Toxoplasma gondii and Cryptosporidium parvum lack detectable DNA cytosine methylation. Eukaryot. Cell 7, 537-540 (2008).
35. Coban, C. et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201, 19-25 (2005).
36. Parroche, P. et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl Acad. Sci. USA 104, 1919-1924 (2007).
37. Hall, J. A. et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29, 637-649 (2008).
38. Rose, W. A., Sakamoto, K. and Leifer, C. A. TLR9 is important for protection against intestinal damage and for intestinal repair. Sci. Rep. 2, 14 (2012).
39. Egan, C. E., Cohen, S. B. and Denkers, E. Y. Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger. Immunol. Cell Biol. 90, 668-675 (2012).
40. Campos, M. A. et al. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol. 172, 1711-1718 (2004).
41. Krishnegowda, G. et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280, 8606-8616 (2005).
42. Del Rio, L. et al. Toxoplasma gondii triggers myeloid differentiation factor 88-dependent IL-12 and chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct parasite molecules and host receptors. J. Immunol. 172, 6954-6960 (2004).
43. Chang, H. R., Grau, G. E. and Pechere, J. C. Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology 69, 33-37 (1990).
44. Sibley, L. D., Adams, L. B., Fukutomi, Y. and Krahenbuhl, J. L. Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages. J. Immunol. 147, 2340-2345 (1991).
45. Deckert-Schluter, M., Bluethmann, H., Rang, A., Hof, H. and Schluter, D. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J. Immunol. 160, 3427-3436 (1998).
46. Yap, G. S., Scharton-Kersten, T., Charest, H. and Sher, A. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160, 1340-1345 (1998).
47. Hunter, C. A., Chizzonite, R. and Remington, J. S. IL-1β is required for IL-12 to induce production of IFNγ by NK cells. A role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens. J. Immunol. 155, 4347-4354 (1995).
48. Ju, C. H., Chockalingam, A. and Leifer, C. A. Early response of mucosal epithelial cells during Toxoplasma gondii infection. J. Immunol. 183, 7420-7427 (2009).
49. Mun, H. S. et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Immunol. 15, 1081-1087 (2003).
50. Erridge, C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J. Leukoc. Biol. 87, 989-999 (2010).
51. Reiling, N. et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169, 3480-3484 (2002).
52. Debierre-Grockiego, F. and Schwarz, R. T. Immunological reactions in response to apicomplexan glycosylphosphatidylinositols. Glycobiology 20, 801-811 (2010).
53. Zhu, J., Krishnegowda, G., Li, G. and Gowda, D. C. Proinflammatory responses by glycosylphosphatidyl-inositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1. Exp. Parasitol. 128, 205-211 (2011).
54. Mun, H. S. et al. Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70. Infect. Immun. 73, 4634-4642 (2005).
55. Witola, W. H. et al. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect. Immun. 79, 756-766 (2011).
56. Gov, L., Karimzadeh, A., Ueno, N. and Lodoen, M. B. Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15. mBio 4, e00255-e00213 (2013).
57. Ewald, S. E., Chavarria-Smith, J. and Boothroyd, J. C. NLRP1 is an inflammasome sensor for Toxoplasma gondii. Infect. Immun. 11, 11 (2013).
58. Gazzinelli, R. T. et al. Parasite-induced IL-12 stimulates early IFNγ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153, 2533-2543 (1994).
59. Hunter, C. A., Candolfi, E., Subauste, C., Van Cleave, V. and Remington, J. S. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84, 16-20 (1995).
60. Khan, I. A., Matsuura, T. and Kasper, L. H. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62, 1639-1642 (1994).
61. Scharton-Kersten, T. M., Yap, G., Magram, J. and Sher, A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261-1273 (1997).
62. Lieberman, L. A. et al. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J. Immunol. 173, 1887-1893 (2004).
63. Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev. Immunol. 3, 133-146 (2003).
64. Scharton-Kersten, T. M. et al. In the absence of endogenous IFNγ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157, 4045-4054 (1996).
65. Scharton-Kersten, T., Contursi, C., Masumi, A., Sher, A. and Ozato, K. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186, 1523-1534 (1997).
66. Mashayekhi, M. et al. CD8α+ dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35, 249-259 (2011).
67. Honda, K. et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035-1040 (2005).
68. Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243-249 (2005).
69. Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S. and Sher, A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl Acad. Sci. USA 90, 6115-6119 (1993).
70. Hunter, C. A., Subauste, C. S., Van Cleave, V. H. and Remington, J. S. Production of γ-interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor-α. Infect. Immun. 62, 2818-2824 (1994).
71. Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100 (2008).
72. Schiavoni, G. et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8α+ dendritic cells. J. Exp. Med. 196, 1415-1425 (2002).
73. Tsujimura, H., Tamura, T. and Ozato, K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J. Immunol. 170, 1131-1135 (2003).
74. Tussiwand, R. et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490, 502-507 (2012).
75. Seillet, C. et al. CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3. Blood 121, 1574-1583 (2013).
76. Iwasaki, A. and Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science 327, 291-295 (2010).
77. Blander, J. M. and Medzhitov, R. On regulation of phagosome maturation and antigen presentation. Nature Immunol. 7, 1029-1035 (2006).
78. West, M. A. et al. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305, 1153-1157 (2004).
79. Atif, S. M., Uematsu, S., Akira, S. and McSorley, S. J. CD103-CD11b+ dendritic cells regulate the sensitivity of CD4 T-cell responses to bacterial flagellin. Mucosal Immunol. 1, 25 (2013).
80. Letran, S. E. et al. TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity. Eur. J. Immunol. 41, 29-38 (2011).
81. Raetz, M. et al. Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFNγ-dependent elimination of Paneth cells. Nature Immunol. 14, 136-142 (2013).
82. Sukhumavasi, W. et al. TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J. Immunol. 181, 3464-3473 (2008).
83. Sibley, L. D. Invasion and intracellular survival by protozoan parasites. Immunol. Rev. 240, 72-91 (2011).
84. Mordue, D. G., Hakansson, S., Niesman, I. and Sibley, L. D. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp. Parasitol. 92, 87-99 (1999).
85. McKee, A. S., Dzierszinski, F., Boes, M., Roos, D. S. and Pearce, E. J. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii. J. Immunol. 173, 2632-2640 (2004).
86. Lang, C., Algner, M., Beinert, N., Gross, U. and Luder, C. G. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFNγ-induced major histocompatibility complex class II gene expression. Microbes Infect. 8, 1994-2005 (2006).
87. Leng, J., Butcher, B. A. and Denkers, E. Y. Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances. Parasite Immunol. 31, 717-728 (2009).
88. Mordue, D. G. and Sibley, L. D. Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. J. Immunol. 159, 4452-4459 (1997).
89. Gubbels, M. J., Striepen, B., Shastri, N., Turkoz, M. and Robey, E. A. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect. Immun. 73, 703-711 (2005).
90. Dzierszinski, F. et al. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect. Immun. 75, 5200-5209 (2007).
91. Sinai, A. P., Webster, P. and Joiner, K. A. Association of host cell endoplasmic reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole membrane: a high affinity interaction. J. Cell Sci. 110, 2117-2128 (1997).
92. Goldszmid, R. S. et al. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J. Exp. Med. 206, 399-410 (2009).
93. Blanchard, N. et al. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nature Immunol. 9, 937-944 (2008).
94. Gregg, B. et al. Subcellular antigen location influences T-cell activation during acute infection with Toxoplasma gondii. PLoS ONE 6, 28 (2011).
95. John, B. et al. Dynamic Imaging of CD8+ T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog. 5, 3 (2009).
96. Koshy, A. A. et al. Toxoplasma co-opts host cells it does not invade. PLoS Pathog. 8, 26 (2012).
97. Wilson, D. C. et al. Differential regulation of effector-and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathog. 6, 1000815 (2010).
98. Yap, G., Pesin, M. and Sher, A. Cutting edge: IL-12 is required for the maintenance of IFNγ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165, 628-631 (2000).
99. Scharton-Kersten, T., Caspar, P., Sher, A. and Denkers, E. Y. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-γ production induced by an attenuated parasite strain. Exp. Parasitol. 84, 102-114 (1996).
100. Sturge, C. R. et al. TLR-independent neutrophil-derived IFNγ is important for host resistance to intracellular pathogens. Proc. Natl Acad. Sci. USA 110, 10711-10716 (2013).
101. Yarovinsky, F., Hieny, S. and Sher, A. Recognition of Toxoplasma gondii by TLR11 prevents parasite-induced immunopathology. J. Immunol. 181, 8478-8484 (2008).
102. Nathan, C. F., Murray, H. W., Wiebe, M. E. and Rubin, B. Y. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670-689 (1983).
103. Murray, H. W., Gellene, R. A., Libby, D. M., Rothermel, C. D. and Rubin, B. Y. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-γ. J. Immunol. 135, 2374-2377 (1985).
104. Pfefferkorn, E. R. Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl Acad. Sci. USA 81, 908-912 (1984).
105. Pfefferkorn, E. R., Rebhun, S. and Eckel, M. Characterization of an indoleamine 2,3-dioxygenase induced by γ-interferon in cultured human fibroblasts. J. Interferon Res. 6, 267-279 (1986).
106. Ball, H. J. et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396, 203-213 (2007).
107. Metz, R. et al. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67, 7082-7087 (2007).
108. Divanovic, S. et al. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J. Infect. Dis. 205, 152-161 (2012).
109. Adams, L. B., Hibbs, J. B. Jr., Taintor, R. R. and Krahenbuhl, J. L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144, 2725-2729 (1990).
110. Fang, F. C. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nature Rev. Microbiol. 2, 820-832 (2004).
111. Fox, B. A., Gigley, J. P. and Bzik, D. J. Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. Int. J. Parasitol. 34, 323-331 (2004).
112. Butcher, B. A. et al. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog. 7, 8 (2011).
113. El Kasmi, K. C. et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nature Immunol. 9, 1399-1406 (2008).
114. Yap, G. S. and Sher, A. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)- α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189, 1083-1092 (1999).
115. Schluter, D. et al. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. J. Immunol. 162, 3512-3518 (1999).
116. Khan, I. A., Matsuura, T. and Kasper, L. H. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J. Immunol. 161, 2994-3000 (1998).
117. Suzuki, Y., Kang, H., Parmley, S., Lim, S. and Park, D. Induction of tumor necrosis factor-α and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-γ in genetically resistant BALB/c mice. Microbes Infect. 2, 455-462 (2000).
118. Murray, H. W. and Teitelbaum, R. F. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165, 513-517 (1992).
119. Murray, H. W., Juangbhanich, C. W., Nathan, C. F. and Cohn, Z. A. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. J. Exp. Med. 150, 950-964 (1979).
120. Wilson, C. B., Tsai, V. and Remington, J. S. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J. Exp. Med. 151, 328-346 (1980).
121. Chang, H. R. and Pechere, J. C. Macrophage oxidative metabolism and intracellular Toxoplasma gondii. Microb. Pathog. 7, 37-44 (1989).
122. Taylor, G. A. and Feng, C. G, and Sher, A. p47 GTPases: regulators of immunity to intracellular pathogens. Nature Rev. Immunol. 4, 100-109 (2004).
123. Bekpen, C. et al. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol. 6, 31 (2005).
124. Taylor, G. A. et al. Pathogen-specific loss of host resistance in mice lacking the IFNγ-inducible gene IGTP. Proc. Natl Acad. Sci. USA 97, 751-755 (2000).
125. Collazo, C. M. et al. Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194, 181-188 (2001).
126. Liesenfeld, O. et al. The IFNγ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS ONE 6, 17 (2011).
127. Fentress, S. J. et al. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8, 484-495 (2010).
128. Zhao, Y. O., Khaminets, A., Hunn, J. P. and Howard, J. C. Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNγ-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog. 5, 6 (2009).
129. Martens, S. et al. Mechanisms regulating the positioning of mouse p47 resistance GTPases LRG-47 and IIGP1 on cellular membranes: retargeting to plasma membrane induced by phagocytosis. J. Immunol. 173, 2594-2606 (2004).
130. Butcher, B. A. et al. p47 GTPases regulate Toxoplasma gondii survival in activated macrophages. Infect. Immun. 73, 3278-3286 (2005).
131. Hunn, J. P. et al. Regulatory interactions between IRG resistance GTPases in the cellular response to Toxoplasma gondii. EMBO J. 27, 2495-2509 (2008).
132. Zhao, Y. O., Konen-Waisman, S., Taylor, G. A., Martens, S. and Howard, J. C. Localisation and mislocalisation of the interferon-inducible immunity-related GTPase, Irgm1 (LRG-47) in mouse cells. PLoS ONE 5, 0008648 (2010).
133. Liu, Z. et al. The immunity-related GTPase Irgm3 relieves endoplasmic reticulum stress response during coxsackievirus B3 infection via a PI3K/Akt dependent pathway. Cell. Microbiol. 14, 133-146 (2012).
134. Taylor, G. A. et al. The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J. Biol. Chem. 272, 10639-10645 (1997).
135. Henry, S. C. et al. Balance of Irgm protein activities determines IFNγ-induced host defense. J. Leukoc. Biol. 85, 877-885 (2009).
136. Khaminets, A. et al. Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell. Microbiol. 12, 939-961 (2010).
137. Ling, Y. M. et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp. Med. 203, 2063-2071 (2006).
138. Martens, S. et al. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 1, 18 (2005).
139. Hunn, J. P. and Howard, J. C. The mouse resistance protein Irgm1 (LRG-47): a regulator or an effector of pathogen defense? PLoS Pathog. 6, 1001008 (2010).
140. Feng, C. G., Zheng, L., Lenardo, M. J. and Sher, A. Interferon-inducible immunity-related GTPase Irgm1 regulates IFNγ-dependent host defense, lymphocyte survival and autophagy. Autophagy 5, 232-234 (2009).
141. Henry, S. C. et al. Regulation of macrophage motility by Irgm1. J. Leukoc. Biol. 87, 333-343 (2010).
142. Feng, C. G. et al. The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-γ-induced cell death. Nature Immunol. 9, 1279-1287 (2008).
143. Feng, C. G., Weksberg, D. C., Taylor, G. A., Sher, A. and Goodell, M. A. The p47 GTPase Lrg-47 (Irgm1) links host defense and hematopoietic stem cell proliferation. Cell Stem Cell 2, 83-89 (2008).
144. Selleck, E. M. et al. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog. 9, 25 (2013).
145. Yamamoto, M. et al. ATF6β is a host cellular target of the Toxoplasma gondii virulence factor ROP18. J. Exp. Med. 208, 1533-1546 (2011).
146. Behnke, M. S. et al. The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18. PLoS Pathog. 8, 8 (2012).
147. Steinfeldt, T. et al. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol. 8, 1000576 (2010).
148. Bekpen, C., Xavier, R. J. and Eichler, E. E. Human IRGM gene "to be or not to be". Semin. Immunopathol. 32, 437-444 (2010).
149. McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nature Genet. 40, 1107-1112 (2008).
150. Degrandi, D. et al. Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J. Immunol. 179, 7729-7740 (2007).
151. Kresse, A. et al. Analyses of murine GBP homology clusters based on in silico, in vitro and in vivo studies. BMC Genomics 9, 1471-2164 (2008).
152. Yamamoto, M. et al. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37, 302-313 (2012).
153. Degrandi, D. et al. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc. Natl Acad. Sci. USA 110, 294-299 (2013).
154. Haldar, A. K. et al. IRG and GBP host resistance factors target aberrant, "non-self" vacuoles characterized by the missing of "self" IRGM proteins. PLoS Pathog. 9, 13 (2013).
155. Roach, J. C. et al. The evolution of vertebrate Toll-like receptors. Proc. Natl Acad. Sci. USA 102, 9577-9582 (2005).
156. Melo, M. B., Jensen, K. D. and Saeij, J. P. Toxoplasma gondii effectors are master regulators of the inflammatory response. Trends Parasitol. 27, 487-495 (2011).